迈普医学
(301033)
| 流通市值：29.99亿 | | | 总市值：35.63亿 |
| 流通股本：5693.51万 | | | 总股本：6763.10万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 294,321,686.63 | 189,801,626.51 | 78,362,845.65 | 368,830,564.59 |
| 营业收入 | 294,321,686.63 | 189,801,626.51 | 78,362,845.65 | 368,830,564.59 |
| 二、营业总成本 | 198,969,081.21 | 128,608,088.16 | 57,213,511.8 | 255,227,189.08 |
| 营业成本 | 57,913,490.99 | 39,929,561.54 | 16,639,943.57 | 72,924,429.61 |
| 税金及附加 | 5,102,028.06 | 2,959,981.01 | 1,069,621.35 | 6,746,492.02 |
| 销售费用 | 50,058,279.56 | 31,163,771.42 | 13,900,058.72 | 66,461,330.41 |
| 管理费用 | 53,619,886.47 | 34,517,581.35 | 15,870,550.3 | 72,954,855.91 |
| 研发费用 | 29,804,492.88 | 18,246,698.91 | 8,807,395.01 | 36,961,839.76 |
| 财务费用 | 2,470,903.25 | 1,790,493.93 | 925,942.85 | -821,758.63 |
| 其中:利息费用 | 164,001.86 | 82,130.85 | - | 19,718.01 |
| 其中:利息收入 | 1,287,347.49 | 761,503.93 | 313,130.44 | 1,582,619.93 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 112,218.81 | 291,865.26 | 232,344.82 | 185,028.55 |
| 加:投资收益 | 2,686,422.63 | 1,711,902.97 | 882,847.76 | 2,938,077.08 |
| 资产处置收益 | 0 | - | - | 6,437.07 |
| 资产减值损失(新) | -1,188,458.47 | -925,993.42 | -504,515.91 | -2,681,608.94 |
| 信用减值损失(新) | -67,380.63 | -80,638.51 | -5,140.45 | -195,808.27 |
| 其他收益 | 7,018,847.55 | 4,946,786.04 | 2,008,680.8 | 14,154,054.2 |
| 四、营业利润 | 103,914,255.31 | 67,137,460.69 | 23,763,550.87 | 128,009,555.2 |
| 加:营业外收入 | 27,221.12 | 5,000.34 | 5,000.34 | 1,620,980.12 |
| 减:营业外支出 | 755,530.87 | 577,762.06 | 2,538.61 | 3,458,136.45 |
| 五、利润总额 | 103,185,945.56 | 66,564,698.97 | 23,766,012.6 | 126,172,398.87 |
| 减:所得税费用 | 12,786,161.72 | 9,984,165.4 | 3,050,630.48 | 13,043,960.35 |
| 六、净利润 | 90,399,783.84 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 90,399,783.84 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 90,399,783.84 | 56,580,533.57 | 20,715,382.12 | 113,128,438.52 |
| 扣除非经常损益后的净利润 | 86,685,811.73 | 53,937,463.57 | 19,525,648.41 | 105,438,127.51 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.35 | 0.85 | 0.31 | 1.71 |
| (二)稀释每股收益 | 1.34 | 0.84 | 0.31 | 1.69 |
| 八、其他综合收益 | -114,498.01 | -88,615.72 | -67,015.5 | 75,537.46 |
| 归属于母公司股东的其他综合收益 | -114,498.01 | -88,615.72 | -67,015.5 | 75,537.46 |
| 九、综合收益总额 | 90,285,285.83 | 56,491,917.85 | 20,648,366.62 | 113,203,975.98 |
| 归属于母公司股东的综合收益总额 | 90,285,285.83 | 56,491,917.85 | 20,648,366.62 | 113,203,975.98 |
| 公告日期 | 2026-10-22 | 2026-08-21 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |